SCHEMBL22018174

SCHEMBL22018174

CCOC(=O)c1cnn2cccc2c1-c1ccccccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.54
KDM4E B2RXH2 8/20 0.53
HSD17B10 Q99714 4/20 0.53
SMN1; SMN2 Q16637 8/20 0.49
HPGD P15428 7/20 0.49
RAB9A P51151 7/20 0.49
NPC1 O15118 6/20 0.49
MAPT P10636 5/20 0.48
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
TSHR P16473 1/20 0.48
GAA P10253 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
LMNA P02545 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
NFKB1 P19838 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15883632 0.84 ALDH1A1 (0.56) ALDH1A1KDM4EHSD17B10SMN1; SMN2HPGD
SCHEMBL600704 0.84 ALDH1A1 (0.67) ALDH1A1KDM4EHSD17B10SMN1; SMN2HPGD
SCHEMBL9920357 0.82 ALDH1A1 (0.54) ALDH1A1KDM4EHSD17B10SMN1; SMN2HPGD
SCHEMBL22018175 0.81 CAMKK1 (0.46) ALDH1A1KDM4ESMN1; SMN2HPGDRAB9A
SCHEMBL9920355 0.81 ALDH1A1 (0.53) ALDH1A1KDM4EHSD17B10SMN1; SMN2HPGD
SCHEMBL13212873 0.80 ALDH1A1 (0.54) ALDH1A1KDM4EHSD17B10SMN1; SMN2HPGD
SCHEMBL9052351 0.75 ALDH1A1 (0.64) ALDH1A1KDM4ESMN1; SMN2HPGDRAB9A
SCHEMBL31338931 0.75 ALDH1A1 (0.56) ALDH1A1KDM4EHSD17B10SMN1; SMN2HPGD
SCHEMBL3183698 0.74 TSHR (0.54) ALDH1A1KDM4EHSD17B10SMN1; SMN2HPGD
SCHEMBL13213080 0.74 ALDH1A1 (0.56) ALDH1A1KDM4EHSD17B10SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10828290-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors INCYTE CORPORATION (US) 2020-11-10 US disclosed
US-20200155527-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE HOLDINGS CORPORATION 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200155527-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS PIM2, PIM1, PIM3 ALDH1A1 1912/4885KDM4E 913/4885HSD17B10 3416/4885
US-10828290-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors PIM2, PIM1, PIM3 ALDH1A1 1912/4885KDM4E 913/4885HSD17B10 3416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.